Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular effects of atomoxetine in children, adolescents, and adults.
Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, Quintana H, Lipetz R, Michelson D, Heiligenstein J. Wernicke JF, et al. Among authors: michelson d. Drug Saf. 2003;26(10):729-40. doi: 10.2165/00002018-200326100-00006. Drug Saf. 2003. PMID: 12862507 Review.
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD.
Buitelaar JK, Danckaerts M, Gillberg C, Zuddas A, Becker K, Bouvard M, Fagan J, Gadoros J, Harpin V, Hazell P, Johnson M, Lerman-Sagie T, Soutullo CA, Wolanczyk T, Zeiner P, Fouche DS, Krikke-Workel J, Zhang S, Michelson D; Stomoxetine International Study Group. Buitelaar JK, et al. Among authors: michelson d. Eur Child Adolesc Psychiatry. 2004 Aug;13(4):249-57. doi: 10.1007/s00787-004-0401-3. Eur Child Adolesc Psychiatry. 2004. PMID: 15365896 Clinical Trial.
A comparison of North American versus non-North American ADHD study populations.
Buitelaar JK, Barton J, Danckaerts M, Friedrichs E, Gillberg C, Hazell PL, Hellemans H, Johnson M, Kalverdijk LJ, Masi G, Michelson D, Revol O, Sebastian JS, Zhang S, Zuddas A. Buitelaar JK, et al. Among authors: michelson d. Eur Child Adolesc Psychiatry. 2006 Mar;15(3):177-81. doi: 10.1007/s00787-005-0523-2. Epub 2006 Jan 30. Eur Child Adolesc Psychiatry. 2006. PMID: 16447026
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
Hazell P, Zhang S, Wolańczyk T, Barton J, Johnson M, Zuddas A, Danckaerts M, Ladikos A, Benn D, Yoran-Hegesh R, Zeiner P, Michelson D. Hazell P, et al. Among authors: michelson d. Eur Child Adolesc Psychiatry. 2006 Mar;15(2):105-10. doi: 10.1007/s00787-006-0506-y. Eur Child Adolesc Psychiatry. 2006. PMID: 16523251 Clinical Trial.
242 results